PLX PROTALIX BIOTHERAPEUTICS INC Product Launches 8-K Filing 2023 - FDA Approval Protalix BioTherapeutics and Chiesi Global Rare Diseases announce FDA approval of ELFABRIO for Fabry disease treatment.Get access to all SEC 8-K filings of the PROTALIX BIOTHERAPEUTICS INC